Company profilePharmaceutical#199 of 1,318 in Pakistan1 DRAP alert

DELUX CHEMICAL INDUSTRIES

Pharmaceutical company · 91 brands · 105 molecules

91 registered products 38 pharmaceutical brands 105 distinct molecules 1 DRAP alert

Company overview

91
registered products
38
pharmaceutical brands
105
distinct molecules
0
therapeutic classes
1
DRAP alerts

DELUX CHEMICAL INDUSTRIES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 91 product registrations across 105 distinct molecules. It is the 199th largest registrant in Pakistan by product count. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by DELUX

44 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

44
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202544

Top molecules by brand count

Paracetamol6 brands
Risperidone4 brands
Ibuprofen4 brands
Cefixime3 brands
Menthol3 brands
Sodium Acid2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official67 products · Rs 34.48 – Rs 1,667.04
Median across source: Rs 193.56

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert: Drug Product; Micogen-B Cream (Batch#MB-012/22) by M/s. Delux Chemical Indus
2023-04-05

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SEMOS PHARMACEUTICALS (PVT) LTD. holds 46 molecules not in this portfolio
Amodiaquine 150MgArtemetherArtesunateAscorbic AcidAzithromycinBisacodyl
SEARLE PAKISTAN (PVT.) LTD. holds 224 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
IRZA PHARMA (PVT) LTD. holds 106 molecules not in this portfolio
AcetazolamideAcyclovirAdrenalineAlbendazoleAlbuterolAmikacin

Get the full profile for DELUX

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.